Search / Trial NCT06235372

Evaluation of the Corneal Endothelial Cell Layer by Specular Microscopy in Patients With Thyroid Eye Disease

Launched by ASSIUT UNIVERSITY · Jan 30, 2024

Trial Information

Current as of October 03, 2024

Not yet recruiting

Keywords

Description

Thyroid eye disease is a common periorbital autoimmune inflammatory disease .It significantly impairs quality of the life ,causes cosmetic defects ,and could be sight-threatening ,especially when optic nerve or the cornea is affected.Classic manifestations of thyroid eye disease include proptosis ,lid retraction ,lagophthalmos,optic neuropathy and restrictive extraocular myopathy.In addition to the affection of the orbital and lacrimal glands ,the corneal endothelium has showen morphological changes in patients with thyroid eye disease .corneal endothelium is the innermost corneal layer fac...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patients with thyroid eye disease whom diagnosis was established based on bartley diagnostic criteria .
  • Exclusion Criteria:
  • * participates with systemic diseases other than HT such as
  • 1. diabetes mellitus
  • 2. previous ocular surgery or laser therapy.
  • 3. history of corneal disease.
  • 4. history of trauma.
  • 5. history of glaucoma

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0